Effectiveness and safety of sofosbuvir/velpatasvir in chronic hepatitis C virus infection of Bangladeshi children

Abstract Background We currently advise all pediatric patients with hepatitis C virus (HCV) infection to take oral direct-acting antivirals (DAA), especially pan-genotypic medications. This study looks at how well, safely, and tolerably sofosbuvir-velpatasvir (SOF/VEL) combination therapy works for...

Descripció completa

Dades bibliogràfiques

Autors principals:	Salahuddin Mahmud, Md. Belayet Hossain, Emdadul Haque, Madhabi Baidya, Rafia Rashid, Ahmed Rashidul Hasan, Tanzila Farhana, Farhana Tasneem, Syed Shafi Ahmed
Format:	Artigo
Idioma:	Inglês
Publicat:	SpringerOpen 2025-06-01
Col·lecció:	Egyptian Liver Journal
Matèries:	Hepatitis C virus Children Direct-acting antivirals Pan-genotypic regimen Sofosbuvir-Velpatasvir Sustained virological response
Accés en línia:	https://doi.org/10.1186/s43066-025-00430-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!